Philips Announces DEFINE GPS Global Multicenter Study to Assess Outcomes of PCI Procedures Guided by Integrated iFR and Interventional X-ray Images

Amsterdam, the Netherlands, Feb. 11 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a new randomized controlled trial to assess patient outcomes after receiving a percutaneous coronary intervention (PCI) guided by Philips’ unique co-registration platform, which combines data of an instant wave-Free Ratio (iFR) measurement and the angiogram [...]